Deep Episode 6: Help Them Practice Good Medicine: Marketing to Physicians via EHR

In this episode, John Mangano sits down with Damon Basch, a leader in healthcare provider (HCP) marketing and VP, Strategic Partnerships at Veradigm. Damon shares his journey to becoming an expert in electronic health records (EHR) and clinical workflow communications. With insights from over a decade in the industry, he discusses the evolution of healthcare marketing, the unique challenges of communicating with physicians, and the vital role EHRs play in enhancing patient care.

Damon dives deep into the intricacies of marketing within the healthcare provider ecosystem, focusing on the importance of delivering timely, relevant information to doctors in a way that complements their workflow. He explains how EHR platforms have transformed over the years and why they’re a critical touchpoint for marketers aiming to influence prescription decisions and improve patient outcomes. Tune in to learn about the most valuable ways to reach HCPs at the point of care.

Share this Post

Related Articles

Despite years of progress in healthcare innovation, too many patients in North America still face barriers to care that stem not from biology, but from geography, income, and systemic inequities. Across North America, millions of people live in “care deserts” with limited or no access to hospitals, pharmacies, or primary care providers. These individuals, many […]

Last week, Cannes Lions 2025 brought together the global advertising industry for a week of high-profile programming, creative celebration, and perhaps most importantly, meaningful connection. Panels offered insight into where marketing is headed, and other insights emerged among leaders between sessions. Here are six key takeaways that reflect the shifting priorities, new challenges, and emerging […]

Last week, a new bill called the “End Prescription Drug Ads Now Act” was introduced in Congress, aiming to ban nearly all direct-to-consumer (DTC) pharmaceutical advertising. While the legislation has sparked headlines, its chances of becoming law are slim due to constitutional concerns and bipartisan disagreement. Still, it reflects growing attention to the pharmaceutical industry […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.